- Home
- GPUS vs SLXN Comparison
GPUS vs SLXN Comparison
Compare GPUS & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPUS
- SLXN
- Stock Information
- Founded
- GPUS 1969
- SLXN 2008
- Country
- GPUS United States
- SLXN Israel
- Employees
- GPUS N/A
- SLXN N/A
- Industry
- GPUS
- SLXN
- Sector
- GPUS
- SLXN
- Exchange
- GPUS NYSE
- SLXN NYSE
- Market Cap
- GPUS 4.1M
- SLXN 4.3M
- IPO Year
- GPUS 1996
- SLXN N/A
- Fundamental
- Price
- GPUS $3.10
- SLXN $0.84
- Analyst Decision
- GPUS
- SLXN Strong Buy
- Analyst Count
- GPUS 0
- SLXN 1
- Target Price
- GPUS N/A
- SLXN $9.00
- AVG Volume (30 Days)
- GPUS 85.9K
- SLXN 31.1M
- Earning Date
- GPUS 04-15-2025
- SLXN 03-04-2025
- Dividend Yield
- GPUS N/A
- SLXN N/A
- EPS Growth
- GPUS N/A
- SLXN N/A
- EPS
- GPUS N/A
- SLXN N/A
- Revenue
- GPUS $139,425,000.00
- SLXN N/A
- Revenue This Year
- GPUS N/A
- SLXN N/A
- Revenue Next Year
- GPUS N/A
- SLXN N/A
- P/E Ratio
- GPUS N/A
- SLXN N/A
- Revenue Growth
- GPUS 3.50
- SLXN N/A
- 52 Week Low
- GPUS $2.62
- SLXN $0.21
- 52 Week High
- GPUS $28.03
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- GPUS N/A
- SLXN N/A
- Support Level
- GPUS N/A
- SLXN N/A
- Resistance Level
- GPUS N/A
- SLXN N/A
- Average True Range (ATR)
- GPUS 0.00
- SLXN 0.00
- MACD
- GPUS 0.00
- SLXN 0.00
- Stochastic Oscillator
- GPUS 0.00
- SLXN 0.00
About GPUS HYPERSCALE DATA INC
Hyperscale Data Inc, formerly Ault Alliance Inc is a diversified holding company. It operates a data center at which it mines Bitcoin and provides mission-critical products that support a diverse range of industries, including oil exploration, crane services, defense/aerospace, industrial, automotive, medical/biopharma, consumer electronics, hotel operations and textiles. The company has eight reportable segments: Energy and Infrastructure; Technology and Finance; SMC; Sentinum, Inc.; GIGA; TurnOnGreen; ROI; and Ault Disruptive.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.